John Yates

67 year

Health Technology

Consumer Services

Profile

John Yates served as President & Chief Executive Officer at Takeda Global Research & Development Center, Inc. from 2004 to 2007.
Prior to that, he was Vice President-Medical & Scientific Affairs at Merck & Co., Inc. from 1990 to 2003.
He also served as Chief Medical Officer at Array BioPharma, Inc. from 2007 to 2008.
Currently, he is the Chief Medical Officer at Radius Health, Inc. Dr. Yates holds a doctorate degree from The University of Sheffield.

Former positions of John Yates

Companies	Position	End
ARRAY TECHNOLOGIES, INC.	Chief Tech/Sci/R&D Officer	2008-09-14
Takeda Global Research & Development Center, Inc.	President	2006-12-31
MERCK & CO., INC.	Chief Tech/Sci/R&D Officer	2002-12-31
RADIUS HEALTH, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of John Yates's experience

Training of John Yates

The University of Sheffield

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Yates's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MERCK & CO., INC.	Health Technology

Private companies	3
Array BioPharma, Inc. Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology
Takeda Global Research & Development Center, Inc.

See company connections